California’s stem cell research funding agency is paying for its first human clinical trial, awarding $25 million to Geron Corp. for the early phase of a spinal cord injury trial, the first FDA-approved clinical study using cells from human embryonic stem cells.
The California Institute for Regenerative Medicine’s board voted Wednesday to approve the award, which CIRM Chairman Bob Klein called “a landmark step.”
No comments:
Post a Comment